Biotechnology firms are leveraging computational protein design to optimize candidate therapeutic molecules prior to initiating clinical trial phases.
Pipeline Optimization
Automated screening pipelines have compressed early-stage molecule validation from years to months, sharply reducing preclinical research expenditure.